Mechanistically, gene expression data of urothelial carcinoma cells treated with a different FGFR inhibitor revealed FGFR inhibited T cell chemoattractant CXCL16 and CD8 T cell infiltration and effects were attributed to inhibiting FGFR on cancer cells. Here, CD8A is linked to cancer.